ALEMG — Laboratoires Euromedis SA Income Statement
0.000.00%
Last trade - 00:00
- €14.20m
- €3.84m
- €54.18m
- 66
- 69
- 50
- 69
2018 December 31st | R2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
---|---|---|---|---|---|
Period Length: | 17 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | FAS | FAS | FAS | FAS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 108 | 77.1 | 193 | 112 | 54.2 |
Cost of Revenue | |||||
Gross Profit | 37.4 | 24.9 | 64.2 | 33.5 | 18.7 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 116 | 79.9 | 165 | 105 | 60 |
Operating Profit | -8.6 | -2.83 | 28.7 | 6.42 | -5.8 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -8.16 | -3.15 | 28.4 | 2.52 | -5.98 |
Provision for Income Taxes | |||||
Net Income After Taxes | -6.92 | -3.64 | 22.9 | 2.31 | -5.94 |
Minority Interest | |||||
Equity in Affiliates | |||||
Net Income Before Extraordinary Items | |||||
Net Income | -6.97 | -3.65 | 22.7 | 2.26 | -5.93 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -6.97 | -3.65 | 22.7 | 2.26 | -5.93 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -2.27 | -1.1 | 7.58 | 0.828 | -1.91 |
Dividends per Share |